ZyVersa Therapeutics, Inc. (OTCPK: ZVSA)
Health Care · Biotechnology · US
$0.08
-19.19% today · -50.0% 1Y
ZyVersa Therapeutics, Inc. (OTCPK: ZVSA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $647.67K and employs 6 people.
Over the last twelve months the share price has lost 50.0%, trading between 0.08 and 0.30.
Tweenvest scores ZyVersa Therapeutics, Inc. across four factors: quality 23/100, value 54/100. Its strongest factor is value.
ZVSA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $647.67K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -3.40
- Dividend yield
- —
- Beta (5Y)
- 0.84
- 52-week high
- $0.30
- 52-week low
- $0.08
- Avg volume (3M)
- —
- Shares outstanding
- 8.10M
- Employees
- 6
- Next earnings
- —
About ZyVersa Therapeutics, Inc.
ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to advancing and commercializing therapies for renal (kidney) and inflammatory disorders. The company's pipeline prominently features VAR 200, a cholesterol efflux modulator aimed at addressing kidney diseases such as focal segmental glomerulosclerosis, Alport syndrome, and diabetic kidney disease. Furthermore, ZyVersa is advancing IC 100, a pioneering inflammasome ASC inhibitor positioned to tackle a wide array of inflammatory conditions. The company maintains its corporate headquarters in Weston, Florida.
- ISIN
- US98987D3008
- Founded
- 2014
- Listed since
- Feb 11, 2022
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Smart Agro - LimitedTASE: SMAG | $734.53K | ₪0.54 | +1.12% |
| Nutra Pharma Corp.OTCPK: NPHC | $715.97K | $0.00 | +9900.00% |
| MindBio Therapeutics Corp.CNSX: MBIO | $715.26K | CA$0.14 | -26.32% |
| SQZ Biotechnologies CompanyOTCPK: SQZB | $707.79K | $0.02 | -0.41% |
| Biodexa Pharmaceuticals PlcNasdaqCM: BDRX | $637.92K | $0.62 | -8.30% |
| Entheon Biomedical Corp.CNSX: ENBI.X | $586.97K | CA$0.06 | +20.00% |
| Ludwig Enterprises, Inc.OTCPK: LUDG | $585.08K | $0.00 | -65.00% |
| IntegraGen SAENXTPA: ALINT | $519.56K | €0.04 | -40.86% |
Figures last refreshed Oct 4, 2026.